chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 65.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Herpes zoster, Pain, Pain in extremity
Clinical narrative: Headache; Body ache; Left leg ache; Shingles on left leg, foot and ankle; This is a spontaneous report from a contactable consumer (the patient). A 65-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot Number: EL9262), via an unspecified route of administration, administered in left arm on 09Feb2021 as single dose for COVID-19 immunization. Medical history included bananas allergy, allergies to bug spray, and known allergies to "Gamoglobin" and "Flagti Soln" (as reported), from an unknown date and unknown if ongoing. The patient has no history of COVID prior vaccination. The patient was not COVID tested post vaccination. Concomitant medication included levothyroxine sodium (SYNTHROID) taken for an unspecified indication. The patient previously took cefalexin (CEPHALEXIN), ciprofloxacin, levothyroxine, and neomycin sulfate;polymyxin b sulfate (NEOSPORIN) and experienced drug allergy. The patient previously received the first dose of BNT162B2 (Lot number: EL3302), on 22Jan2021 08:30, on left arm, for COVID-19 immunization. On 12Feb2021, the patient experienced headache, body ache, left leg ache and shingles on left leg, foot and ankle. The events resulted to a doctor or healthcare professional office/clinic visit, and emergency room/department or urgent care. Treatment for the events was Valacyclovir Hcl 1g tablet. Outcome of the events was not recovered.
Age: 41.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A 41-year-old female patient received the second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE lot/batch number and expiration date not reported) via an unspecified route of administration, administered on the left arm on 04Feb2021 13:00 at a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient previously received first dose of BNT162B2 on an unknown date for COVID-19 immunisation. On 10Feb2021 the patient experienced shingles. The event resulted in a doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of the event which included medication (unspecified). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Post vaccination, the patient has not been tested for COVID-19. No known allergies. Outcome of the event was not recovered.  Information on the lot/batch number has been requested.
Age: 40.0
Sex: F
Vaccine: COVID19
Symptoms: Aneurysmal bone cyst, Pain
Clinical narrative: painful lump on my left collar bone; I have a painful lump on my left collar bone. My shot was in my left arm. It appeared a few days after the shot and over a week later it's still there and painful. It's about the size of a grape.; This is a spontaneous report from a contactable consumer (patient). A 40-year-old (non-pregnant) female patient received first dose of COVID-19 VACCINE, Solution for injection, Batch/Lot number was not reported), via an unspecified route of administration, administered in left arm on 12 Feb  2021 13:45 as single dose for covid-19 immunisation. There was no medical history. Concomitant medications of patient included (other vaccine in two weeks) duloxetine hydrochloride (CYMBALTA), clonazepam (CLONAZEPAM). There was no other vaccine in four weeks. On 16 Feb 2021, patient experienced have a painful lump on my left collar bone. My shot was in my left arm. It appeared a few days after the shot and over a week later it's still there and painful. It's about the size of a grape. Patient did not receive any treatment. There was no covid prior vaccination and not tested for covid post vaccination. The outcome of event was recovering. Information on the Batch/Lot number has been requested.
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site warmth
Clinical narrative: arm got warm; This is a spontaneous report from a contactable consumer(patient) via Pfizer sponsored program. A male patient of an unspecified age received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Batch/Lot number: unknown, Expiry date: unknown), via an unspecified route of administration on an unspecified date as SINGLE DOSE for covid-19 immunization. The patient's medical history and concomitant medications were not reported. Patient experienced First shot arm got warm. Second shot arm got warm. Had no other AE. The outcome of the event was reported as unknown.  Information on the lot/batch number has been requested.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Blood test, Chills, Erythema, Hypersomnia, Pruritus
Clinical narrative: Swelling face; Chills; Face is deep red; following day my face started getting red; Swelling is going down a little bit now, but it itches; Swelling is going down a little bit now, but it itches; I have been sleeping for 2 days; This is a spontaneous report received from a contactable consumer (patient). An 84-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection and Lot Number: EL3247) via an unspecified route of administration on 11Feb2021 as single dose for COVID-19 immunization. The patient medical history included Blood pressure. Concomitant medication included VITAMINS NOS. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EJ1686; Expiration Date: unknown) on 21Jan2021 for COVID-19 immunization. The patient experienced swelling face, chills, face is deep red; following day my face started getting red swelling is going down a little bit now, but it itches, I have been sleeping for 2 days. The patient underwent lab tests and procedures which included blood test and results was unknown on 21Jan2021. The outcome of events swelling face, chills, face is deep red; following day my face started getting red, swelling is going down a little bit now, but itches was unknown. The swelling is going down a little bit now was recovering. The outcome of event I have been sleeping for 2 days was recovered on an unspecified date.
Age: 83.0
Sex: M
Vaccine: COVID19
Symptoms: Swelling, Swelling face
Clinical narrative: Swelling face; Chills; Face is deep red; following day my face started getting red; Swelling is going down a little bit now, but it itches; Swelling is going down a little bit now, but it itches; I have been sleeping for 2 days; This is a spontaneous report received from a contactable consumer (patient). An 84-year-old male patient received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection and Lot Number: EL3247) via an unspecified route of administration on 11Feb2021 as single dose for COVID-19 immunization. The patient medical history included Blood pressure. Concomitant medication included VITAMINS NOS. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, Lot Number: EJ1686; Expiration Date: unknown) on 21Jan2021 for COVID-19 immunization. The patient experienced swelling face, chills, face is deep red; following day my face started getting red swelling is going down a little bit now, but it itches, I have been sleeping for 2 days. The patient underwent lab tests and procedures which included blood test and results was unknown on 21Jan2021. The outcome of events swelling face, chills, face is deep red; following day my face started getting red, swelling is going down a little bit now, but itches was unknown. The swelling is going down a little bit now was recovering. The outcome of event I have been sleeping for 2 days was recovered on an unspecified date.
Age: 86.0
Sex: F
Vaccine: COVID19
Symptoms: Condition aggravated, Pain in extremity, Peripheral swelling
Clinical narrative: swelling in right hand; right hand pain; right hand pain worsened; This is a spontaneous report received from a contactable consumer. The consumer reported for an 86-year-old female patient (mom) that she received second dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, and Lot Number: EL9269) intramuscularly administered in right arm on 09Feb2021 11:30 as single dose for COVID-19 immunization. The patient medical history included atrial fibrillation (diagnosed about 15-20 years ago, more like 15 years), thyroid, blood pressure, and for heart issues, sinus issues, cholesterol and arthritis all are ongoing. Concomitant medications included atorvastatin, fexofenadine hydrochloride (ALLEGRA), levothyroxine, metoprolol tartrate, spironolactone and warfarin. The patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: Solution for injection, and Lot Number: EL3249 or EL2249) intramuscularly administered in right arm on 19Jan2021 11:30am as single dose for COVID-19 immunization and She has been getting the flu vaccine for years. On 10Feb2021, the patient experienced pain in her right hand, she got the vaccine shot in her right arm. On 10Feb2021, the right hand pain was reported as worsened. On an unspecified date, the subject noticed swelling on her right hand, the patient did not think she had the swelling before. It was reported that the swelling was not huge, but it was troublesome, and the patient had to take her coffee with her left hand. It was reported that it had just been 36 hours after the patient had the injection and she was still experiencing the pain. Around 9 or 10 last night her mom was complaining, and she wonders if it happened because of the injection. The patient did not experience injection site swelling. The patient did not take any treatment she was just resting. The outcome of events right hand pain and right hand pain worsened was not recovered and swelling in right hand was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (the patient) from a Pfizer-sponsored program COVAX US Support. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Batch/Lot number was not reported), via an unspecified route of administration on an unspecified date as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient has an appointment for the second dose on Friday (unspecified date) but ended up in the Emergency room due to shingles. She's on antiviral and wanted to know if she will continue getting the second dose. The outcome of the event was unknown.   Information on the lot/batch number has been requested.
Age: 55.0
Sex: M
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: pain at the injection site (left arm)/injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 55-year-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Lot Number: EL 3247), via an unspecified route of administration, administered in left arm on 22Feb2021 13:30 at single dose for COVID-19 immunization at workplace clinic. Medical history included elevated levels of LDL (Low density lipoprotein) for the past 3+ years. No allergies to medications, food, or other products. Concomitant medication included atorvastatin at 20 mg, single. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 22Feb2021 19:00, the patient experienced pain at the injection site (left arm)/ injection site soreness in the night. The patient did not receive treatment for the event. The outcome of the event was recovering.  No follow up attempts are needed. No further information is expected.
Age: 56.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I developed shingles about a week after my first dose; This is a spontaneous report from a contactable other health professional (patient). A 56-year-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: EI3247), via an unspecified route of administration, administered in Arm Right on 17Jan2021 as single dose for COVID-19 immunization. The patient's medical history was not reported. No known allergies. There were no concomitant medications. No other vaccines taken in four weeks. No COVID-19 prior to vaccination and not been tested for COVID-19 post vaccination. On 24Jan2021, the patient developed shingles a week after first dose. The patient was reporting it because she had read some reports that this happened to others and there could possibly be a link. The patient visited a physician's office and was given antiviral and pain meds. The outcome of the event was recovering. The patient received the second dose of bnt162b2 (Lot number: EI9264) on 08Feb2021 in the right arm for COVID-19 immunization.
Sex: F
Vaccine: COVID19
Symptoms: Ear pain, Headache, Herpes zoster, Pain in jaw
Clinical narrative: shingles; shooting pain in her head; shooting pain in her head, ear and jaw in the left side; shooting pain in her head, ear and jaw in the left side; This is a spontaneous report from a contactable consumer (patient) via Medical information team. A female patient of an unspecified age (Age: 82, Unit: Unknown) received BNT162B2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE), dose 1 via an unspecified route of administration on 21Jan2021 (Batch/Lot number was not reported) as SINGLE DOSE for COVID-19 immunization. The patient's medical history was and concomitant medications were not reported. On 22Jan2021, the patient experienced a shooting pain in her head, ear and jaw in the left side which is the same side where she got the shot. Two days later on 23Jan2021, the patient broke out in shingles, her doctor told her that the vaccine may have triggered the shingles. She may receive the second dose of the vaccine on 27Feb, she would like to know if it's okay for her to receive the second dose of the vaccine due to the shingles. The outcome of the events was unknown.  Information regarding Lot/Batch number requested.
Sex: U
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 via an unspecified route of administration on 21Feb2021 (Batch/Lot number was not reported) as a single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced shingles on an unspecified date with outcome of unknown. There is a little shingle maybe 4 or 5. Patient went to see the doctor and he gave the patient an antibody for shingles. Patient did not know if it was an antibiotic or it is supposed to be antiviral. Medication is Famciclovir, 500 mg and the doctor wanted the patient to take it 3 times a day for 7 days.  Information on the lot/batch number has been requested.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: shingles; This is a spontaneous report from a contactable consumer (patient). A female patient of an unspecified age (Age: 69, Unit: Unknown) received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection; Batch/Lot number was not reported), via an unspecified route of administration on 22Feb2021 as single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient experienced shingles on an unspecified date. The patient wanted to know whether being on pregabalin (LYRICA) and gabapentin would diminish the effect of the Pfizer COVID vaccine. She has read online that taking acetaminophen (TYLENOL) will diminish the effect of the vaccine. The patient reported that she received the 1st dose of the Pfizer COVID vaccine last night (22Feb2021) and has been prescribed pregabalin today (23Feb2021) for the case of the shingles. The patient wanted to know where else she can refer to for additional information on drug interactions. The outcome of the event was unknown.  Information on the batch/lot number has been requested.
Age: 74.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Shingles; This is a spontaneous report from a contactable consumer (patient). A 74-year-old female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 1 at the age of 74-year-old, via an unspecified route of administration on 31Jan2021 (Lot number and expiration date was not reported) as single dose for COVID-19 immunisation. Medical history included being diabetic. Concomitant medications included unspecified other medications (that was a long list). The patient previously took a shingles shot on 2007 (reported as 14 years ago). The patient has had her first COVID-19 shot on 31Jan2021 and was due to have the second COVID-19 shot on 21Feb2021, this coming Sunday. She had gotten shingles on an unspecified date in 2021, after the first dose. She has been to a doctor (office visit), when she was going crazy with pain and itching all that. She went to the doctor and they gave her Acyclovir, 800 mg that she was taking and got to take it for 2 more days. She was also given a cream to put on. She did not have shingles as bad as other people because she had the first shingles shot 14 years ago. But now, she was wondering with taking this antiviral pill, taking 5 of them a day and then put on the cream, if she was still going to be able to get her second shot on Sunday. Itching and all that was getting better with the cream, but she was taking 5 of the pills a day for a couple of more days. The patient was recovering from the event.  Information on the lot/batch number has been requested.
Age: 55.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Palpitations, Pyrexia
Clinical narrative: Fever 100.4; Heart Palpitations; Headache; This is a spontaneous report from a contactable other healthcare professional (patient). A 55-year-old non-pregnant female patient first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9267), via unspecified route of administration on left arm on 12Feb2021 12:00 PM (at the age of 55-year-old) as a single dose for COVID-19 immunization. The patient's medical history was not reported. Concomitant medications included quetiapine fumarate (SEROQUEL), alprazolam (XANAX) atorvastatin (LIPITOR [ATORVASTATIN]), acetylsalicylic acid (BABY ASPIRIN) and lamotrigine (LAMICTAL). On 16Feb2021 14:00, the patient experienced fever 100.4, heart palpitations and headache. No treatment medications were received for the adverse events. Outcome of the events was not recovered.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Myalgia
Clinical narrative: soreness in muscle in right arm with movement.; This is a spontaneous report from a contactable consumer or other non-HCP. A 60-years-old male patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot Number: EL3247), via an unspecified route of administration, administered in Arm Right on 17Feb2021 02:15 as SINGLE DOSE for covid-19 immunization. Medical history included hypertension. Other medical history: mild hypertension. Concomitant medication(s) included ibuprofen. The patient did not receive any other vaccine in four weeks. The patient did not had COVID prior vaccination and the patient did not tested for COVID 19 post vaccination. No known allergies reported for the patient. On 18Feb2021 07:00 the patient experienced soreness in muscle in right arm with movement. The outcome of event was not recovered.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Rash macular, Urticaria
Clinical narrative: Rash that started on chest and moved to the torso, then arms and legs over 1 week; Extremely itchy; hives all over body; small red blotches; This is a spontaneous report from a contactable nurse(patient). An adult non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Batch/Lot number was not reported), second dose intramuscular, administered in right arm on 01Feb2021 as SINGLE DOSE for covid-19 immunization. Medical history included neuropathy from an unknown date and unknown if ongoing. Patient had no known allergies. Patient did not had covid prior to vaccination. Patient was not tested for Covid post vaccination. Concomitant medication included estradiol, estriol, estrone (TRIEST estrogen replacement) taken for an unspecified indication, start and stop date were not reported. Patient received first dose of BNT162B2 via intramuscular route in right arm on 15Jan2021 at 01:00. On 08Feb2021 at 03:00, the patient experienced rash that started on chest and moved to the torso, then arms and legs over 1 week, extremely itchy, hives all over body and small red blotches. Extremely itchy, small red blotches, hives all over body. Patient received medication treatment for adverse events. The patient recovered with lasting effects. Therapeutic measures were taken as a result of events. Outcome of the events was recovered with sequel.   Information about lot/batch number has been requested.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Abdominal pain upper, Burning sensation, Computerised tomogram, Headache, Herpes zoster
Clinical narrative: Very late diagnosing as shingles; Headache at work after vaccine; then got more severe along with leg very sensitive and burning feeling; then got more severe along with leg very sensitive and burning feeling; severe stomach pain; This is a spontaneous report from a contactable other HCP (patient). A 61-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 28Jan2021 09:00 (at 61 years old), single dose for covid-19 immunisation. Medical history included concussion, endometriosis, all from an unknown date. Concomitant medications included estradiol; progesterone. No  other vaccine in four weeks. On 28Jan2021 09:00, patient experienced Headache at work after vaccine , then got more severe along with leg very sensitive and burning feeling, better then 5 nights very severe stomach pain-Dr appt and ER to get sonogram, CT-Very late diagnosing as shingles. The outcome of the events was not recovered. Treatment of adverse events was CT, Sonogram. No covid prior vaccination. Not covid tested post vaccination.  No Known allergies.  Information about lot/ batch number has been requested; Sender's Comments: Based on known disease pathophysiology, the event herpes zoster is assessed as not related to suspect vaccine BNT162B2.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Sensory disturbance, Ultrasound scan
Clinical narrative: Very late diagnosing as shingles; Headache at work after vaccine; then got more severe along with leg very sensitive and burning feeling; then got more severe along with leg very sensitive and burning feeling; severe stomach pain; This is a spontaneous report from a contactable other HCP (patient). A 61-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 28Jan2021 09:00 (at 61 years old), single dose for covid-19 immunisation. Medical history included concussion, endometriosis, all from an unknown date. Concomitant medications included estradiol; progesterone. No  other vaccine in four weeks. On 28Jan2021 09:00, patient experienced Headache at work after vaccine , then got more severe along with leg very sensitive and burning feeling, better then 5 nights very severe stomach pain-Dr appt and ER to get sonogram, CT-Very late diagnosing as shingles. The outcome of the events was not recovered. Treatment of adverse events was CT, Sonogram. No covid prior vaccination. Not covid tested post vaccination.  No Known allergies.  Information about lot/ batch number has been requested; Sender's Comments: Based on known disease pathophysiology, the event herpes zoster is assessed as not related to suspect vaccine BNT162B2.
Age: 61.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Hyperaesthesia, Ultrasound scan
Clinical narrative: Very late diagnosing as shingles; Headache at work after vaccine; then got more severe along with leg very sensitive and burning feeling; then got more severe along with leg very sensitive and burning feeling; severe stomach pain; This is a spontaneous report from a contactable other HCP (patient). A 61-year-old female patient (not pregnant) received bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE), first dose via an unspecified route of administration, administered in Arm Left on 28Jan2021 09:00 (at 61 years old), single dose for covid-19 immunisation. Medical history included concussion, endometriosis, all from an unknown date. Concomitant medications included estradiol; progesterone. No  other vaccine in four weeks. On 28Jan2021 09:00, patient experienced Headache at work after vaccine , then got more severe along with leg very sensitive and burning feeling, better then 5 nights very severe stomach pain-Dr appt and ER to get sonogram, CT-Very late diagnosing as shingles. The outcome of the events was not recovered. Treatment of adverse events was CT, Sonogram. No covid prior vaccination. Not covid tested post vaccination.  No Known allergies.  Information about lot/ batch number has been requested; Sender's Comments: Based on known disease pathophysiology, the event herpes zoster is assessed as not related to suspect vaccine BNT162B2.
Sex: U
Vaccine: COVID19
Symptoms: Burning sensation, Fatigue, Headache, Herpes zoster
Clinical narrative: Legs were burning; Felt very tired; Shingles; Headache; This is a spontaneous report from a contactable consumer (patient). A patient of unspecified age and gender received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE; Lot Number was not reported), via an unspecified route of administration, on an unspecified date, at a single dose, for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. The patient had a question about the vaccine. The patient took COVID-19 vaccine and had a reaction. The patient had to take second shot of vaccine this morning (19Feb2021) but wanted to talk to someone if the patient should take it or not. After the patient took the vaccine, the patient was having a really bad headache for 5 days and the legs were burning on an unspecified date. The patient felt very tired and was later diagnosed with shingles on an unspecified date after having COVID-19 vaccine. The patient wanted to ask if he/she should take the second shot of COVID-19 vaccine this morning or not. The patient had an appointment at 9 o'clock this morning to get that shot and wanted to know if he/she should get it or not as the patient had active shingles. The patient recovered from "Headache" on an unspecified date. The patient had not yet recovered from "Shingles". The outcome of the other events was unknown.  Information about lot number and expiration date for the suspect product will be requested in follow-up attempts.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster reactivation
Clinical narrative: mild shingles outbreak after her first COVID-19 vaccine shot/has shingles outbreaks now and then and that it was not untypical for the patient to have mild shingle outbreaks; This is a spontaneous report from a contactable physician via a Pfizer-sponsored program. A female patient of an unspecified age received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE Solution for injection, lot number and expiry date not reported), via an unspecified route of administration, on an unspecified date, as single dose, for COVID-19 immunisation. Medical history included mild shingles outbreaks. Concomitant medications were not reported. On an unspecified date, after her first COVID-19 vaccine shot, the patient experienced a mild shingles outbreak. The physician reported that the patient has shingles outbreaks now and then and that it was not untypical for the patient to have mild shingle outbreaks. The shingles outbreaks stay mild. The patient's second dose was scheduled on 23Feb2021. The physician asked if the patient would be able to get her second COVID-19 Vaccine while having a mild shingles outbreak. The outcome of the event was not recovered.  Information on lot/batch number has been requested.
Age: 27.0
Sex: F
Vaccine: COVID19, COVID19
Symptoms: Chills, Pyrexia, Vaccination site pain
Clinical narrative: slight fever; chills; Injection site soreness; This is a spontaneous report from a contactable consumer (patient). A 27-Year-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 24Feb2021at 03:30 PM as single dose for COVID-19 immunization. Patient previously took first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Solution for injection, Lot number: EL3247), via an unspecified route of administration in left arm on 03Feb2021 at 03:30 PM as single dose for COVID-19 immunization. Medical history was not reported. Patient had no known allergies. Concomitant medications included vitamin d NOS, desogestrel, ethinylestradiol (APRI) as birth Control. The patient was not diagnosed with COVID-19 prior to vaccination. The patient was not tested for COVID-19 since the vaccination. Patient was not pregnant at the time of vaccination. On 24Feb2021 at 09:00 PM (after second vaccine dose) patient experienced slight fever and chills about 5 hours after vaccination. The next day, fever and chills continued. Injection site soreness started a few hours after vaccination and has become quite. No treatment was received. The outcome of the events was recovering.   No follow-up attempts are possible. No further information is expected.
Age: 45.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster, Inappropriate schedule of product administration, Off label use, SARS-CoV-2 test
Clinical narrative: Shingles outbreak started in right armpit.  spread to mid chest to mid back wrapping through armpit; first dose of bnt162b2 on 24Jan2021 01:00 PM/ bnt162b2, dose 2 on 10Feb2021 10:00; first dose of bnt162b2 on 24Jan2021 01:00 PM/ bnt162b2, dose 2 on 10Feb2021 10:00; This is a spontaneous report from a contactable consumer (patient). A 45-years-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE; Batch/Lot Number: EL9269), dose 2 via an unspecified route of administration, administered in Arm Right on 10Feb2021 10:00 (45-years-old) as single dose for COVID-19 immunization. Medical history included Surgery left shoulder from 07Jan2021 to 07Jan2021 (so injection was in right arm). No known allergies. Patient was not pregnant. Patient had no covid prior vaccination. Patient was tested for covid post vaccination. Facility type vaccine was Hospital. Concomitant medication included naproxen sodium (ALEVE) start and stop date were not reported (stopped 48hrs before). The patient previously took first dose of bnt162b2 (lot number: EL9262) on 24Jan2021 01:00 PM (45-years-old) on right arm for COVID-19 immunization. The patient experienced shingles outbreak, started in right armpit and has spread to mid chest to mid back wrapping through armpit on 20Feb2021 07:00, resulted in Doctor or other healthcare professional office/clinic visit and Emergency room/department or urgent care. The patient underwent lab tests and procedures which included RT-PCR (Nasal Swab): Negative on 24Feb2021. The outcome of the event Shingles was recovering. Therapeutic measures were taken as a result of event, medication (valtrex, gabapentin,codeine#3).
Age: 79.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Lethargy
Clinical narrative: Lethargy second and third day, but then felt fine afterwards; Dizziness during evening of vaccination and next day; This is a spontaneous report from a contactable consumer (patient). A 79-year-old non-pregnant female patient received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, lot number was EN6201 and expiration date was not reported), via an unspecified route of administration, administered in arm left on 18Feb2021 at 09:30 (at the age of 79-year-old) as single dose for COVID-19 immunization. The patient other medical history and concomitant medications were not reported. The patient previously took quinolones and had allergies. The patient did not receive other vaccine in four weeks. The patient did not receive other medications in two weeks. The patient did not have COVID prior vaccination. The patient did not COVID tested post vaccination. On 18Feb2021 at 20:15, the patient experienced dizziness during evening of vaccination and next day and lethargy on second and third day, but then felt fine afterwards. The patient did not receive treatment for the events. The outcome of the events was recovered on an unknown date in 2021.   No follow-up attempts are possible. No further information is expected.
Age: 63.0
Sex: F
Vaccine: COVID19
Symptoms: Glycosylated haemoglobin, Rash erythematous
Clinical narrative: Entire body covered in a red rash; This is a spontaneous report from a contactable consumer (patient). A 63-year-old (non pregnant) female consumer received BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9266 and expiration date was not reported), dose 2 via an unspecified route of administration, in left arm on 23Feb2021 12.30 as single dose for COVID-19 immunization. The patient previously received the first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot number: EL9265 and expiration date was not reported), via an unspecified route of administration, in left arm on 02Feb2021 16.45 as single dose for COVID-19 immunization. Medical history included Type 2 diabetic (recent A1C is 6.1) and soap sensitive. The concomitant medications included Januvia, Jardiance, Glipizide and Rouvest. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. The patient was not diagnosed with COVID-19, prior to vaccination and the patient was not tested positive for COVID-19, since the vaccination. On 25Feb2021 at 21:00, the patient had entire body covered in a red rash. The outcome of the event was reported as not recovered.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Malaise, Myalgia
Clinical narrative: Entire body ached in muscles; Did not feel well at all; This is a spontaneous report from a contactable consumer (patient). A 60-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Formulation: Solution for injection, Lot number: EL9267, expiration date not reported), via an unspecified route of administration in left arm on 23Feb2021 at 13:30 (age at the time of vaccination 60-year-old) as a single dose for COVID-19 immunization. COVID-19 vaccine was administered in hospital. Patient had a medical history of bronchitis and Raynaud. The patient received thyroid medications within 2 weeks of vaccination. Patient did not receive other vaccine in four weeks prior to the COVID-19 vaccine. The patient was not diagnosed with COVID-19 prior vaccination. The patient did not undergo COVID-19 test post vaccination. The patient had no known allergies to medications, food other products to his knowledge. On 23Feb2021 (the same day of vaccination) at 20:00, the patients entire body ached in muscles and did not felt well. Reportedly, for three full days my entire body ached in my muscles. Did not feel well at all. The patient did not receive any treatment for the events. The case was assessed as non-serious as per reporter with no seriousness criteria like results in death/life threatening/cause/prolonged hospitalization/Disabling/Incapacitating/Congenital anomaly/birth defect. The outcome of the events was recovering.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Fatigue, Pain, Pyrexia, Vaccination site pain
Clinical narrative: Fatigue; body aches; low grade fever of 100.3; pain at injection site; This is a spontaneous report from a contactable consumer. A 69-years-old non-pregnant female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EL9266), via an unspecified route of administration on 24Feb2021 15:00 as SINGLE DOSE in Arm Left for covid-19 immunization. Medical history included: Paroxysmal Afib and mild COPD. The patient has no allergies. The patient received first dose of bnt162b2 (Lot Number: EN9581) via an unspecified route of administration on 03Feb2021 at 12:45 as SINGLE DOSE in right arm for covid-19 immunization. The patient did not receive any other vaccines in four weeks prior to the COVID vaccine. Concomitant medication(s) included: levothyroxine sodium (SYNTHROID), apixaban (ELIQUIS), metoprolol succinate (TOPROL) and umeclidinium bromide, vilanterol trifenatate (ANORO). The patient was not pregnant at the time of vaccination. Prior to the vaccination the patient was not diagnosed with COVID-19. On 25Feb2021 10:00, the patient experienced fatigue, body aches, low grade fever of 100.3, pain at injection site. The patient underwent lab tests and procedures which included body temperature: 100.3 on 25Feb2021. The patient did not receive treatment for adverse events. Since the vaccination the patient had not been tested for COVID-19. The outcome of the events was recovered on an unspecified date in 2021.  No follow-up attempts are Possible. Information on lot/batch cannot be obtained.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Hyperhidrosis, Pain in extremity, Pyrexia, Tremor
Clinical narrative: I started feeling worst anymore and woke up and my arm was sore; little sore onthe injection site; I started feeling worst anymore and woke up and my arm was sore; Rigorous, just shaking uncontrollably; Fever; profuse sweating; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 60-years-old female (non pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: en6201), dose 1 via an unspecified route of administration on 20Feb2021 13:30 (at the age of 60-years-old) as SINGLE DOSE for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was other medications the patient received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 to vaccination. Medical history included drug hypersensitivity, seasonal allergy, blood pressure increased, vascular device user from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  The patient had the Covid vaccine on Saturday afternoon and didn't feel anything. She was really impress the way it went. Sunday, on an unspecified date, she started feeling worst anymore and woke up and her arm was sore. It was not that big deal. Then by Sunday night on 21Feb2021 , she started to have a severe not chills but rigorous she meant just rigorous, just shaking uncontrollably and then her fever went up. This was same thing Monday and sweat so bad so profusely (on 21Feb2021). But it was such a violent reaction, she was wondering was that normal. She was enquiring that she should get second dose or what. She meant it was, she better today. She felt like she had been drunk to (statement incomplete). She had not none of today but that was terrible. She asked was that normal. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the adverse event  rigorous, just shaking uncontrollably, fever and profuse sweating. The outcome of event i started feeling worst anymore and woke up and my arm was sore, little sore on the injection site was unknown. The outcome of rest event was not recovered.  No follow-up attempts are needed. No further information is expected
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pain
Clinical narrative: I started feeling worst anymore and woke up and my arm was sore; little sore onthe injection site; I started feeling worst anymore and woke up and my arm was sore; Rigorous, just shaking uncontrollably; Fever; profuse sweating; This is a spontaneous report from a contactable consumer or other non hcp (Patient). A 60-years-old female (non pregnant) patient received bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: en6201), dose 1 via an unspecified route of administration on 20Feb2021 13:30 (at the age of 60-years-old) as SINGLE DOSE for covid-19 immunization. The patient was not pregnant at the time of vaccination. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. There was other medications the patient received within 2 weeks of vaccination. The patient was not diagnosed with COVID-19 to vaccination. Medical history included drug hypersensitivity, seasonal allergy, blood pressure increased, vascular device user from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported.  The patient had the Covid vaccine on Saturday afternoon and didn't feel anything. She was really impress the way it went. Sunday, on an unspecified date, she started feeling worst anymore and woke up and her arm was sore. It was not that big deal. Then by Sunday night on 21Feb2021 , she started to have a severe not chills but rigorous she meant just rigorous, just shaking uncontrollably and then her fever went up. This was same thing Monday and sweat so bad so profusely (on 21Feb2021). But it was such a violent reaction, she was wondering was that normal. She was enquiring that she should get second dose or what. She meant it was, she better today. She felt like she had been drunk to (statement incomplete). She had not none of today but that was terrible. She asked was that normal. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received treatment for the adverse event  rigorous, just shaking uncontrollably, fever and profuse sweating. The outcome of event i started feeling worst anymore and woke up and my arm was sore, little sore on the injection site was unknown. The outcome of rest event was not recovered.  No follow-up attempts are needed. No further information is expected
Age: 73.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Rotator cuff syndrome, Vaccination site pain
Clinical narrative: Site pain in left shoulder; Deep muscle pain; loss of rotator cuff movement without discomfort/pain; This is a spontaneous report from a contactable consumer (patient). A 73-year-old female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, lot number: Pfizer ek:6/2L:EM:9810), via an unspecified route of administration administered in left arm on 05Feb2021 15:00 (at the age of 73-year-old) as SINGLE DOSE for COVID-19 immunisation. The patient was not pregnant at the time of vaccination. The patient had no COVID prior vaccination and was not COVID tested post vaccination. Medical history included high cholesterol, some back injuries, and known allergies with sulfur drugs and Flagyl. Concomitant medications included rosuvastatin calcium (CRESTOR) and diazepam (VALIUM). On 05Feb2021, the patient experienced site pain in left shoulder which has increased over three weeks, deep muscle pain, and loss of rotator cuff movement without discomfort/pain. There was no treatment received for all events. The patient had not yet recovered from all events.  No follow-up attempts are possible. No further information is expected.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea
Clinical narrative: Diarrhea; This is a spontaneous report received from a contactable consumer A 72-year-old female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, Solution for injection, Batch/Lot Number: EN6198), via an unspecified route of administration, on Arm Right on 27Feb2021 at 08:00  as single dose for covid-19 immunization. The patient was not pregnant at the time of vaccination. Medical history included allergy to Lisinopril. The patient took other medications within two weeks.The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine.The patient was not tested for COVID-19 post vaccination and was not diagnosed with COVID-19 prior to vaccination.On 28Feb2021,the patient developed diarrhea and continued to have on 01Mar2021 this day reported. The patient was taking loperamide for treatment and consulted via phone call and spoke with PCP regarding the diarrhea on morning of 01Mar2021.The outcome of event was recovering.  No follow-up attempts are possible. No further information is expected.
Age: 52.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Vertigo
Clinical narrative: Dizziness; Vertigo; This is a spontaneous report from a contactable consumer reported for a patient. A 52-year-old male patient received first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 VACCINE, Solution for injection, Lot number and expiration was not provided) via an unspecified route of administration, administered in left arm on 22Feb2021 09:15 am (age at vaccination was 52 years) as single dose for COVID-19 immunization.The patient's medical history included known allergies: Penicillin. Concomitant medications included Prilosec Omeprazole Magnesium, Crestor and Bystolic.On 23Feb2021 at 02:00 am, the patient experienced dizziness and vertigo. The facility where the most recent COVID-19 vaccine was administered was other. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. No treatment was received for the adverse events. The outcome of the events was not recovered.  No follow-up attempts are possible; information about lot/batch number cannot be obtained.
Age: 66.0
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: I had an adverse reaction to my second shot; I got shingles.; This is a spontaneous report from a contactable consumer (patient).  A 66-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Lot Number: EN6200 and expiration date not provided), via an unspecified route of administration, administered in Arm Right second dose on an unspecified date at single dose for covid-19 immunisation. The patient's medical history and concomitant medications were not reported. The patient historical vaccine includes bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE) first dose on an unspecified date for Covid-19 immunisation. On an unspecified date, the patient got shingles.  The patient just put creams on it so that to make it feel better but no medicines. The outcome of the event was unknown.
Sex: F
Vaccine: COVID19
Symptoms: Herpes zoster
Clinical narrative: Diagnosed with shingles; This is a spontaneous report from a contactable other health professional. A 67-year-old female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE), dose 2 via an unspecified route of administration, administered in Arm Right on 10Feb2021 at 08:30 (Batch/Lot Number: Unknown) as single dose for COVID-19 immunization. The patient medical history and concomitant medications were not reported. The patient previously took vancomycin and experienced allergies, and first dose of bnt162b2 on 21Jan2021 at 09:30(lot number: unknown) for COVID-19 immunization. 20Feb2021 (reported as 10 days after second Pfizer COVID vaccination), the patient was diagnosed with shingles. The event resulted in doctor or other healthcare professional office/clinic visit. The patient received treatment for the event with valacyclovir. The outcome of the event was not recovered. The patient has no COVID prior to vaccination and was not tested post vaccination.  Information on the lot/batch number has been requested.